Close Menu

NEW YORK — A research team from the University of Colorado Cancer Center has received a $3 million grant from the National Cancer Institute to identify the genetic drivers of aggressive prostate cancer.

With the five-year grant, CU Cancer Center's James Costello and colleagues will knock out various prostate cancer-associated genes in a mouse model and identify which develop aggressive disease. RNA sequencing will be used to compare and contrast the gene expression and pathways between the models. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Sponsored by

This webinar will address how two molecular laboratories are implementing tertiary analysis software to improve their precision oncology workflows.

Sponsored by
Thermo Fisher Scientific

This webinar will review how liquid biopsy can be considered as an alternative and non-invasive method to tissue biopsy for cancer molecular characterization.

Sponsored by

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.  

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.